NCT02142322 2025-04-17
Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer
Seoul National University Hospital
Phase 2 Completed
Clinical Trials
21 trialsNCT04195828 2025-04-01
Camrelizumab Combined with Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer
Fujian Medical University
Phase 2 Completed
NCT06706895 2024-11-27
A Single-arm, Single-center Phase II Clinical Study on the Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection Combined With Fruquintinib Capsules in the Second-line Treatment of Patients With Advanced Gastric Cancer
Shanghai Zhongshan Hospital
Phase 2 Not yet recruiting
NCT03579784 2024-04-19
Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer
Seoul National University Hospital
Phase 2 Active not recruiting
NCT02935634 2023-06-09
FRACTION-GC
Bristol-Myers Squibb
Phase 2 Completed
NCT04890392 2021-08-12
Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT00976768 2020-01-07
Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin
Asan Medical Center
Phase 2 Completed
NCT02451956 2019-12-30
Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy
Samsung Medical Center
Phase 2 Completed
NCT03954756 2019-05-17
Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT01503372 2019-02-12
PaFLO
Charite University, Berlin, Germany
Phase 2 Completed
NCT03564834 2018-09-28
Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer Patients
Peking University
Phase 2 Unknown
NCT03137004 2017-05-08
Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT01152853 2015-11-20
PF299804-AGC
Seoul National University Hospital
Phase 2 Completed
NCT00842491 2015-05-19
Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer
Peking University
Phase 2 Completed
NCT02072317 2014-02-26
Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer
Fudan University
Phase 2 Unknown
NCT02071043 2014-02-25
Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis
Shanghai Zhongshan Hospital
Phase 2 Completed
NCT02038621 2014-01-16
GZH-001
The Second People's Hospital of Sichuan
Phase 2 Unknown
NCT01851941 2013-05-13
A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer
Seoul National University Hospital
Phase 2 Completed
NCT01238055 2013-04-09
Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer
Samsung Medical Center
Phase 2 Completed
NCT00992199 2010-09-08
IPchemo-AGC
Fudan University
Phase 2 Unknown
NCT00743964 2010-01-15
Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC)
Samsung Medical Center
Phase 2 Completed